14-3-3 sigma/SFN antibody (Middle Region)
Quick Overview for 14-3-3 sigma/SFN antibody (Middle Region) (ABIN634143)
Target
See all 14-3-3 sigma/SFN (SFN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- SFN antibody was raised against the middle region of SFN
-
Purification
- Affinity purified
-
Immunogen
- SFN antibody was raised using the middle region of SFN corresponding to a region with amino acids FHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLT
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SFN Blocking Peptide, (ABIN938309), is also available for use as a blocking control in assays to test for specificity of this SFN antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SFN antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- 14-3-3 sigma/SFN (SFN) (Stratifin (SFN))
-
Alternative Name
- SFN
-
Background
- SFN is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathway. SFN binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. When bound to KRT17, SFN regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway.
-
Molecular Weight
- 28 kDa (MW of target protein)
-
Pathways
- p53 Signaling, Myometrial Relaxation and Contraction
Target
-